CRKL and malignant colon neoplasm: For instance, ZEB2-AS1 could enhance epithelial-mesenchymal transition through the miR-1205/CRKL pathway in colorectal cancer (38) and may be involved in the occurrence and development of colon cancer by regulating the glycolysis process through the miR-188/TAB3 pathway (39).